Clinical features of systemic sclerosis

Systemic sclerosis is characterised by scleroderma1, inflammation and fibrosis of multiple organs and tissues. Two main disease variants exist, defined by the extent of skin involvement:

  • limited systemic sclerosis
  • diffuse systemic sclerosis.

Clinical features of systemic sclerosis by organ system or body region are listed in Clinical features of systemic sclerosis. For images of some of the characteristic features, see Diffuse cutaneous systemic sclerosis and Limited cutaneous systemic sclerosis.

Raynaud phenomenon and gastro-oesophageal reflux are often the first symptoms of systemic sclerosis.Denton, 2017

Table 1. Clinical features of systemic sclerosis[NB1]

Organ system or body region affected by systemic sclerosis

Clinical features

Skin and subcutaneous tissue

scleroedema (early stage)

inflammation, oedema, pruritis, thickening of the skin

scleroderma [NB2] (later stages)

local or general skin thickening and fibrosis

linear scleroderma

atrophic skin with loss of sebaceous gland and hair follicles

facial change

change in cosmetic appearance (eg tight, shiny, thickened skin)

reduced oral aperture and trismus

see images of facial changes in diffuse disease and limited disease

digital fibrosis

sclerodactyly

digital contractures

calcinosis and ulcers (calcinosis cutis)

deposition of insoluble calcium in the skin and subcutaneous tissues

painful calcinotic deposits that may extrude and ulcerate; see calcinosis cutis

Oral and dental

oral mucosa

sicca symptoms (dry mouth), oral ulcers

dentition

difficult dental hygiene

gum and dental disease, secondary to small oral aperture, trismus and sicca

Ophthalmic

ocular surface

keratoconjunctivitis sicca (dry eyes)

Musculoskeletal

joints and muscles

arthralgias, arthritis, tenosynovitis, myalgias, myositis (especially overlap myositis)

Gastrointestinal tract

oesophagus

oesophageal dysmotility, gastro-oesophageal reflux, dysphagia, oesophageal stricture, risk of pulmonary aspiration

stomach

gastric dysmotility and delayed emptying

small intestine

intestinal dysmotility, diarrhoea, malabsorption, bacterial overgrowth

large intestine

constipation, faecal impaction, incontinence, rectal prolapse

Respiratory

upper airways

hoarseness and cough associated with sicca symptoms (dry throat)

lung

interstitial lung disease and pulmonary fibrosis

pulmonary aspiration, aspiration pneumonitis

pulmonary vasculature

fibrosis of pulmonary vascular bed resulting in pulmonary arterial hypertension

Genitourinary tract

kidney

scleroderma renal crisis—accelerated hypertension and acute kidney failure in systemic sclerosis

vagina

dryness

Cardiovascular

vasculopathies

telangiectasiae, abnormal nailfold capillaries

Raynaud phenomenon and digital ischaemia

hypertension

heart

heart failure, especially cor pulmonale secondary to pulmonary hypertension

fibrosis of myocardial, pericardial and conducting tissue

Nonspecific features and functional effects

nonspecific features

fatigue

weight loss, malnutrition

increased risk of common cancers

functional impairment of hand

limited ability to perform occupational tasks and activities of daily living

functional impairment of feet

pain, abnormal gait, pressure areas, ulcers

Note:

NB1: This list is not exhaustive.

NB2: Scleroderma is a term for excessive collagen deposition leading to fibrosis or thickening of the skin.

Figure 1. Diffuse cutaneous systemic sclerosis

Note:

(A) Severe skin involvement in diffuse cutaneous systemic sclerosis has an effect on facial appearance. (B) Hand function is affected in these patients and is often associated with severe digital ulcers and ulceration over areas of pressure or trauma. (C) Atrophic changes of late-stage diffuse skin involvement with prominent hair regrowth. (D) Typical blanching of indurated thickened, hairless skin over the length of the limbs is shown in a patient with early diffuse systemic sclerosis and anti-RNA polymerase antibody positivity. (E) Atrophic changes of the hands in late-stage diffuse skin involvement.

Reproduced from Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390(10103):1685-99 with permission from Elsevier. https://www.ncbi.nlm.nih.gov/pubmed/28413064

Figure 2. Limited cutaneous systemic sclerosis

Note:

Limited cutaneous systemic sclerosis is associated with mild skin involvement distal to the elbows and knees, with or without face and neck involvement, and sparing of the chest and abdomen. (A) Perioral soft-tissue loss. (B) Sclerodactyly. (C) Facial telangiectasis. (D) Dilated nailfold capillaries. (E) Extensive calcinosis cutis.

Reproduced from Denton CP, Khanna D. Systemic sclerosis. Lancet 2017;390(10103):1685-99 with permission from Elsevier. https://www.ncbi.nlm.nih.gov/pubmed/28413064

People who have newly diagnosed systemic sclerosis and positive RNA polymerase III autoantibodies have an increased risk of developing common cancersWeeding, 2020 and scleroderma renal crisis. Malignancy may occur approximately twice as frequently in this subgroup of people compared with the general population and commonly arises around the time of diagnosis. Clinical vigilance for malignancy (eg breast, lung) is important in this subgroup.

1 Scleroderma is a term for excessive collagen deposition leading to fibrosis or thickening of the skin.Return